| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 6.990 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 7.190 | 6 | 0 | 0 | 0 | 448 | 0 | 0 | 0 |
| Total Expenses - EUR | 9 | 377 | 173 | 0 | 0 | 656 | 3 | 3.346 | 3.827 | 0 |
| Gross Profit/Loss - EUR | -9 | 6.813 | -167 | 0 | 0 | -656 | 445 | -3.346 | -3.827 | 0 |
| Net Profit/Loss - EUR | -9 | 6.590 | -167 | 0 | 0 | -656 | 431 | -3.346 | -3.827 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Maya Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 30.791 | 37.102 | 35.614 | 35.746 | 0 | 32.916 | 32.630 | 29.229 | 25.303 | 25.162 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.118 | 22.915 | 7.582 | 22.973 | 0 | 20.627 | 20.618 | 22.716 | 19.882 | 19.770 |
| Cash | 12.673 | 14.187 | 28.033 | 12.773 | 0 | 12.288 | 12.012 | 6.514 | 5.421 | 5.391 |
| Shareholders Funds | 29.856 | 36.159 | 35.380 | 34.731 | 0 | 32.756 | 32.461 | 29.216 | 25.300 | 25.159 |
| Social Capital | 45 | 45 | 44 | 43 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | 935 | 943 | 234 | 1.015 | 0 | 159 | 169 | 14 | 3 | 3 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Maya Pharm Srl